| Title: | A polygenic risk score model for psoriasis based on the protein interactions of psoriasis susceptibility loci |
| Journal: | Frontiers in Genetics |
| Published: | 6 Nov 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39568675/ |
| DOI: | https://doi.org/10.3389/fgene.2024.1451679 |
| URL: | https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2024.1451679/pdf |
Publication 14284
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Introduction: Polygenic Risk Scores (PRS) are an emerging tool for predicting an individual's genetic risk to a complex trait. Several methods have been proposed to construct and calculate these scores. Here, we develop a biologically driven PRS using the UK BioBank cohort through validated protein interactions (PPI) and network construction for psoriasis, incorporating variants mapped to the interacting genes of 14 psoriasis susceptibility (PSORS) loci, as identified from previous genetic linkage studies.</p>
Methods: We constructed the PPI network via the implementation of two major meta-databases of protein interactions, and identified variants mapped to the identified PSORS-interacting genes. We selected only European unrelated participants including individuals with psoriasis and randomly selected healthy controls using an at least 1:4 ratio to maximize statistical power. We next compared our PPI-PRS model to (i) clinical risk models and (ii) conventional PRS calculations through p-value thresholding.</p>
Results: Our PPI-PRS model provides comparable results to both clinical risk models and conventional approaches, despite the incorporation of a limited number of variants which have not necessarily reached genome-wide significance (GWS). Exclusion of variants mapped to the HLA-C locus, an established risk locus for psoriasis resulted in highly similar associations compared to our primary model, indicating the contribution of the genetic variability mapped to non-GWS variants in PRS computations.</p>
Discussion: Our findings support the implementation of biologically driven approaches in PRS calculations in psoriasis, highlighting their potential clinical utility in risk assessment and treatment management.</p>
9 Authors
- Charalabos Antonatos
- Fotios Koskeridis
- Christiana M. Ralliou
- Evangelos Evangelou
- Katerina Grafanaki
- Sophia Georgiou
- Konstantinos K. Tsilidis
- Ioanna Tzoulaki
- Yiannis Vasilopoulos
1 Application
| Application ID | Title |
|---|---|
| 22102 | Multivariate approaches for the identification of novel environmental and genetic risk factors for neuropsychiatric disorders, skin cancers and bone-related outcomes. |
Enabling scientific discoveries that improve human health